Canvuparatide

N/A

Report date: 2025/03/04 16:34:33

Base Information

Drug NameCanvuparatide

Drug Alias Namefatty acylated parathyroid (prodrug) hormone agonist(MBX Biosciences)MBX-2109MBX 2109

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionParathyroid hormone receptor agonists

TargetsParathyroid hormone receptor

Therapy Area/IndicationsHypoparathyroidismRenal Insufficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesArgentina

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMBX Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHypoparathyroidismRenal Insufficiency

Inactive IndicationsN/A

ATC CodeN/A